Levodopa motor complications in Parkinson's disease

被引：348

作者：

Obeso, JA ^{[1
]}

Olanow, CW

Nutt, JG

机构：

[1] Clin Univ & Med Sch, Movement Disorders & Basal Ganglia Grp, Dept Neurol & Neurosurg, Ctr Neurosci, Pamplona 31080, Spain

[2] CUNY Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA

[3] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA

来源：

TRENDS IN NEUROSCIENCES | 2000年 / 23卷 / 10期

关键词：

D O I：

10.1016/S1471-1931(00)00031-8

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Parkinson's disease (PD) is an age-related neurodegenerative disorder with an average onset age of 60 years. In the United States, approximately one million persons suffer from PD, and there are 60 000 newly diagnosed cases every year. The estimated cost of PD to society is $27 billion per year. Based on United States Census Bureau projections, it is estimated that the frequency of PD will increase fourfold by the year 2040, making it an even larger burden on patients, their families and society.

引用

页码：S2 / S7

页数：6

共 50 条

[1] Motor complications of treatment with levodopa in Parkinson's disease
García-Escrig, M
Bermejo-Pareja, F
REVISTA DE NEUROLOGIA, 1999, 28 (08) : 799 - 809
[2] Motor complications, levodopa metabolism and progression of Parkinson's disease
Mueller, Thomas
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (07) : 847 - 855
[3] Motor complications of chronic levodopa therapy in Parkinson's disease
Miyawaki, E
Lyons, K
Pahwa, R
Troster, AI
Hubble, J
Smith, D
Busenbark, K
McGuire, D
Michalek, D
Koller, WC
CLINICAL NEUROPHARMACOLOGY, 1997, 20 (06) : 523 - 530
[4] Handicap in Parkinson's disease with levodopa-induced motor complications
Coelho, M.
Correia Guedes, L.
Lobo, P. Pita
Abreu, D.
Albuquerque, L.
Pereira, J. M.
Rosa, M. M.
Ferreira, J. J.
JOURNAL OF NEUROLOGY, 2014, 261 : S291 - S291
[5] Handicap in Parkinson's disease with levodopa-induced motor complications
Coelho, M.
Correia Guedes, L.
Pita Lobo, P.
Abreu, D.
Albuquerque, L.
Pereira, J. M.
Rosa, M. M.
Ferreira, J. J.
EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 439 - 439
[6] Parkinson's disease - Levodopa complications
King, DB
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1999, 26 : S13 - S20
[7] Duodenale levodopa and apomorphine infusion for motor complications in advanced Parkinson's disease
Antonini, Angelo
Jost, Wolfgang H.
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2018, 86 : S5 - S9
[8] Liquid levodopa-carbidopa in advanced Parkinson's disease with motor complications
Yang, Hui-Jun
Ehm, Gwanhee
Kim, Young Eun
Yun, Ji Young
Lee, Woong-Woo
Kim, Aryun
Kim, Han-Joon
Jeon, Beomseok
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 377 : 6 - 11
[9] G2019S mutation and motor complications of levodopa in Parkinson disease
Farhat, Nouha
Ben Romdhane, Sawssan
Nasri, Amina
Hdiji, Olfa
Sakka, Salma
Gargouri, Amina
Ben Djebara, Mouna
Damak, Mariem
Gouider, Riadh
Mhiri, Chokri
NEUROLOGY, 2019, 92 (15)
[10] LEVODOPA-INDUCED MOTOR COMPLICATIONS IN AN INCIDENT PARKINSON'S DISEASE COHORT
Scott, Nicholas W.
Macleod, Angus D.
Counsell, Carl E.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (11):

← 1 2 3 4 5 →